4//SEC Filing
Liang Howard 4
Accession 0001651308-21-000011
CIK 0001651308other
Filed
Jan 18, 7:00 PM ET
Accepted
Jan 19, 5:04 PM ET
Size
19.4 KB
Accession
0001651308-21-000011
Insider Transaction Report
Form 4
BeiGene, Ltd.BGNE
Liang Howard
CFO & Chief Strategy Officer
Transactions
- Sale
American Depositary Shares
2021-01-14$345.15/sh−300$103,546→ 0 total - Sale
American Depositary Shares
2021-01-15$345.54/sh−5,606$1,937,087→ 0 total - Sale
American Depositary Shares
2021-01-14$344.28/sh−1,100$378,710→ 300 total - Exercise/Conversion
American Depositary Shares
2021-01-15$6.50/sh+12,600$81,900→ 12,600 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-01-15−163,800→ 649,000 totalExercise: $0.50Exp: 2025-07-01→ Ordinary Shares (163,800 underlying) - Exercise/Conversion
American Depositary Shares
2021-01-14$6.50/sh+1,400$9,100→ 1,400 total - Sale
American Depositary Shares
2021-01-15$344.38/sh−6,994$2,408,602→ 5,606 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-01-14−18,200→ 812,800 totalExercise: $0.50Exp: 2025-07-01→ Ordinary Shares (18,200 underlying)
Holdings
- 1,573,715
Ordinary Shares
Footnotes (8)
- [F1]Each American Depositary Share represents 13 Ordinary Shares.
- [F2]The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2020.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $344.11 to $344.455, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $345.15 to $345.155, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $344.00 to $344.97, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $345.30 to $345.98, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- [F7]The number of securities underlying each option and the exercise price therefor are represented in ordinary shares.
- [F8]These securities vest over a four-year period as follows: 25% on July 15, 2016, and the remaining in 36 successive equal monthly installments, subject to continued service. All unvested shares subject to this option are subject to accelerated vesting upon a sale event or certain termination events.
Documents
Issuer
BeiGene, Ltd.
CIK 0001651308
Entity typeother
Related Parties
1- filerCIK 0001663427
Filing Metadata
- Form type
- 4
- Filed
- Jan 18, 7:00 PM ET
- Accepted
- Jan 19, 5:04 PM ET
- Size
- 19.4 KB